Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Arcturus Therapeutics Arcturus Therapeutics Receives Clearance of an Investigational New Drug Application to U.S. Food and Drug Administration for ARCT-032, an Investigational Inhaled mRNA Therapeutic to Treat Cystic Fibrosis September 03, 2024 From Arcturus Therapeutics Via Business Wire Tickers ARCT Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics’ COVID-19 Vaccine May 20, 2024 From Arcturus Therapeutics Via Business Wire Tickers ARCT ASX:CSL CSLLY OTC New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster February 05, 2024 From Arcturus Therapeutics Via Business Wire Tickers ARCT ASX:CSL CSLLY OTC CSL and Arcturus Therapeutics’ ARCT-154 Demonstrates Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster December 21, 2023 From Arcturus Therapeutics Via Business Wire Tickers ARCT ASX:CSL CSLLY OTC Arcturus Therapeutics to Attend Upcoming Investor Conferences August 17, 2023 From Arcturus Therapeutics Via Business Wire Tickers ARCT Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded $115 Million in Grants from the Japanese Government August 14, 2023 From Arcturus Therapeutics Via Business Wire Tickers ARCT Arcturus Therapeutics to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 9, 2022 April 27, 2022 From Arcturus Therapeutics Via Business Wire Tickers ARCT Arcturus Therapeutics to Report Fourth Quarter and Year-End 2021 Financial Results and Provide Corporate Update on February 28, 2022 February 16, 2022 From Arcturus Therapeutics Via Business Wire Tickers ARCT Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) January 21, 2022 From Arcturus Therapeutics Via Business Wire Tickers ARCT Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.